Oncternal Therapeutics, Inc.
ONCT · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39 | -$44 | -$31 | -$17 |
| Dep. & Amort. | $0 | -$0 | $0 | $0 |
| Deferred Tax | $0 | $0 | -$0 | -$0 |
| Stock-Based Comp. | $8 | $7 | $6 | $2 |
| Change in WC | $1 | -$0 | -$1 | -$2 |
| Other Non-Cash | -$1 | $0 | $0 | -$0 |
| Operating Cash Flow | -$32 | -$37 | -$27 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$64 | -$26 | $0 | $0 |
| Inv. Sales/Matur. | $65 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$26 | $0 | $0 |
| Investing Cash Flow | $1 | -$26 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $10 | $1 | $114 |
| Stock Repurch. | -$0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1 | $0 |
| Financing Cash Flow | $1 | $10 | $1 | $114 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$30 | -$54 | -$26 | $97 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | $91 | $117 | $20 |
| End Cash | $7 | $37 | $91 | $117 |
| Free Cash Flow | -$32 | -$37 | -$27 | -$17 |